Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins-Reference-Cited by-同舟云学术

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Published:2004-11-07 Issue:12 Volume:10 Page:1344-1351
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kong Weijia,Wei Jing,Abidi Parveen,Lin Meihong,Inaba Satoru,Li Cong,Wang Yanling,Wang Zizheng,Si Shuyi,Pan Huaining,Wang Shukui,Wu Jingdan,Wang Yue,Li Zhuorong,Liu Jingwen,Jiang Jian-Dong

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1135.pdf

Reference39 articles.

1. Brown, M.S. & Goldstein, J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34–47 (1986).

2. Goldstein, J.L. & Brown, M.S. Regulation of the mevalonate pathway. Nature 343, 425–430 (1990).

3. Grundy, S.M. Statin trials and goals of cholesterol-lowering therapy. Circulation 97, 1436–1439 (1998).

4. Ansell, B.J., Watson, K.E. & Fogelman, A.M. An evidence-based assessment of the NCEP adult treatment panel II guidelines. National cholesterol education program. JAMA 282, 2051–2057 (1999).

5. Smith, J.R., Osborne, T.F.G.J.L. & Brown, M.S. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J. Biol. Chem. 265, 2306–2310 (1990).

Cited by 1169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

2. Berberine Alleviates Uterine Inflammation in Rats via Modulating the TLR-2/p-PI3K/p-AKT Axis;International Immunopharmacology;2024-11

3. Evaluation of Lipid Profile Modulation by Berberis asiatica, Withania somnifera, and Their Synergy in Type 2 Diabetic Wistar Rats;Cureus;2024-08-27

4. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

5. Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis;Bone;2024-08